Status:

COMPLETED

Gait Profile Score in Children With Cerebral Palsy (CP): Influence of the CP Type, Treatment With Botulinum Injection and Multilevel Surgery

Lead Sponsor:

Centre Hospitalier Universitaire de Saint Etienne

Conditions:

Cerebral Palsy

Gait Disorders in Children

Eligibility:

All Genders

6-18 years

Brief Summary

Instrumented three dimensional gait analysis (3DGA) permits to record spatial, temporal, kinetics, kinematics and electromyographic (EMG) parameters in order to understand gait impairment in children ...

Eligibility Criteria

Inclusion

  • Etiology of cerebral palsy
  • Unilateral, bilateral, triplegic or quadriplegic forms of cerebral palsy.
  • 6 to 18 years old
  • GMFCS (Gross Motor Function Classification System) I to III
  • Instrumented gait analysis of the laboratory of St-Etienne
  • Absence of botulinum toxin injection or serial casting in the three months after a first instrumented gait analysis.

Exclusion

  • Etiology others than cerebral palsy as defined classically (ex: ischemic infarcts in a child older than two years).
  • Previous surgery in lower-limb.

Key Trial Info

Start Date :

March 6 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 30 2024

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT06505499

Start Date

March 6 2024

End Date

September 30 2024

Last Update

January 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chu de Saint Etienne

Saint-Etienne, France, 42000